We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Amgen Inc | LSE:0R0T | London | Ordinary Share | AMGEN ORD (CDI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.75 | 0.27% | 273.75 | 266.50 | 281.00 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 992 | 16:35:24 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | 28.19B | 6.72B | 12.5510 | 21.75 | 146.11B |
| Date | Time | Source | Headline |
|---|---|---|---|
| 06/10/2023 | 11:30 | UKREG | D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc |
| 05/10/2023 | 13:58 | UKREG | Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc |
| 05/10/2023 | 13:14 | UKREG | D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc |
| 04/10/2023 | 13:38 | UKREG | Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc |
| 04/10/2023 | 10:07 | UKREG | D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc |
| 03/10/2023 | 17:00 | ALNC |  Drugmakers agree to US government price talks amid pushback |
| 03/10/2023 | 13:41 | UKREG | Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc |
| 03/10/2023 | 12:27 | UKREG | D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc |
| 02/10/2023 | 12:53 | UKREG | Geode Capital Management LLC Form 8.3 - Horizon Therapeutics plc |
| 02/10/2023 | 08:05 | UKREG | D E Shaw & Co LP Form 8.3 - Horizon Therapeutics plc |
1 Year Amgen Chart |
Intraday Amgen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
